DNA methylation inhibitor decitabine ameliorates spondyloarthritis by suppressing Th17 responses and epigenetically upregulating VIPR1 in SKG mice
- DOI
- 10.1186/s13075-026-03848-0
- Published
- 2026-06-18
- Container
- Arthritis Research & Therapy
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1186/s13075-026-03848-0,
title = {DNA methylation inhibitor decitabine ameliorates spondyloarthritis by suppressing Th17 responses and epigenetically upregulating VIPR1 in SKG mice},
author = {Hoshiko Furusawa and Goh Murayama and Masaki Nojima and Taiga Kuga and Yukitomo Hagiwara and Yoshiyuki Abe and Makio Kusaoi and Kurisu Tada and Ken Yamaji and Naoto Tamura},
year = {2026},
journal = {Arthritis Research \& Therapy},
doi = {10.1186/s13075-026-03848-0},
url = {https://doi.org/10.1186/s13075-026-03848-0}
}RIS
TY - JOUR TI - DNA methylation inhibitor decitabine ameliorates spondyloarthritis by suppressing Th17 responses and epigenetically upregulating VIPR1 in SKG mice AU - Hoshiko Furusawa AU - Goh Murayama AU - Masaki Nojima AU - Taiga Kuga AU - Yukitomo Hagiwara AU - Yoshiyuki Abe AU - Makio Kusaoi AU - Kurisu Tada AU - Ken Yamaji AU - Naoto Tamura PY - 2026 JO - Arthritis Research & Therapy DO - 10.1186/s13075-026-03848-0 UR - https://doi.org/10.1186/s13075-026-03848-0 ER -
APA
Furusawa, H., Murayama, G., Nojima, M., Kuga, T., Hagiwara, Y., Abe, Y., Kusaoi, M., Tada, K., Yamaji, K., & Tamura, N. (2026). DNA methylation inhibitor decitabine ameliorates spondyloarthritis by suppressing Th17 responses and epigenetically upregulating VIPR1 in SKG mice. Arthritis Research & Therapy. https://doi.org/10.1186/s13075-026-03848-0
Source records
- crossref · retrieved 2026-09-25T22:19:17.205Z